Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | high-affinity choline transporter | 0.0117 | 0.2297 | 0.1981 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0394 | 0.1193 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.2916 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0394 | 0.1352 |
Toxoplasma gondii | transporter, solute:sodium symporter (SSS) family protein | 0.0117 | 0.2297 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0394 | 0.0381 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0394 | 0.1352 |
Onchocerca volvulus | 0.0117 | 0.2297 | 1 | |
Echinococcus multilocularis | lamin | 0.0033 | 0.0394 | 0.0381 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.2297 | 0.7879 |
Echinococcus granulosus | lamin | 0.0033 | 0.0394 | 0.0381 |
Brugia malayi | GH02984p | 0.0117 | 0.2297 | 0.784 |
Echinococcus multilocularis | sodium:myo inositol cotransporter | 0.0458 | 1 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0394 | 0.0381 |
Echinococcus multilocularis | high affinity choline transporter 1 | 0.0117 | 0.2297 | 0.2287 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0394 | 0.0381 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.2916 | 1 |
Echinococcus multilocularis | sodium coupled monocarboxylate transporter 1 | 0.0117 | 0.2297 | 0.2287 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.2297 | 0.7879 |
Schistosoma mansoni | inositol transporter | 0.0458 | 1 | 1 |
Echinococcus granulosus | sodium:glucose cotransporter 2 | 0.0458 | 1 | 1 |
Schistosoma mansoni | inositol transporter | 0.0458 | 1 | 1 |
Echinococcus multilocularis | sodium:glucose cotransporter 2 | 0.0458 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0381 | 0.1306 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0394 | 0.1193 |
Echinococcus multilocularis | solute carrier family 5 | 0.0458 | 1 | 1 |
Schistosoma mansoni | sodium/solute symporter | 0.0117 | 0.2297 | 0.1981 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0394 | 0.0381 |
Echinococcus granulosus | high affinity choline transporter 1 | 0.0117 | 0.2297 | 0.2287 |
Echinococcus granulosus | sodium:myo inositol cotransporter | 0.0458 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0394 | 0.1352 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.2916 | 1 |
Echinococcus granulosus | sodium coupled monocarboxylate transporter 1 | 0.0117 | 0.2297 | 0.2287 |
Brugia malayi | Sodium:solute symporter family protein | 0.0117 | 0.2297 | 0.784 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0013 | 0.0046 |
Echinococcus granulosus | solute carrier family 5 | 0.0458 | 1 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0053 | 0.018 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 23.2809 uM | PUBCHEM_BIOASSAY: Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2660, AID2666, AID2667, AID2668, AID2681, AID504465] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 84.9214 uM | PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.